Coronavirus prevention vaccine

Johnson & Johnson Single-Shot Vaccine Could Be Ready by June

Reading now: 846
justjared.com

There’s a new coronavirus vaccine that has the science community feeling hopeful. Johnson & Johnson released Phase 3 trial data on Friday (January 29), showing that their vaccine – a single shot – is 66% effective at preventing symptomatic disease and 85% effective against severe illness, ABC reports.

A team of scientists at the company were “elated” by the results. “We’re a single shot…and now we’ve produced data that say that our vaccine is highly effective, 85% effective against severe COVID, 100% effective against hospitalization or death,” Dr. Mathai Mammen, M.D., Ph.D.

and the global head of Janssen Research & Development said. “We’ve had the objective of producing a vaccine for the world, that is easily used, is easily distributed

Read more on justjared.com
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA